Jackson Square Capital, LLC Tricida, Inc. Transaction History

Jackson Square Capital, LLC

  • $387 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 21, 2021
BUY
$3.56 - $4.64 $17,159 - $22,364
4,820 Added 36.63%
17,978 $83,000
Q4 2019

May 15, 2020
BUY
$29.6 - $43.71 $389,476 - $575,136
13,158 New
13,158 $497,000

Others Institutions Holding TCDA

# of Institutions
4
Shares Held
30K
Call Options Held
124K
Put Options Held
46.5K
View Full List

About Tricida, Inc.

TCDA Quotes by TradingView
  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Jackson Square Capital, LLC Portfolio

Follow Jackson Square Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email